Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
Tango Therapeutics (NASDAQ: TNGX) announced that CEO Barbara Weber, M.D. will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday, November 19, 2025, 4:30–4:55 PM GMT / 11:30–11:55 AM ET. The session will be available live via webcast under the "Events & Presentations" tab on the company's Investors page. A replay will be archived on the company's website for 90 days after the presentation.
Tango Therapeutics (NASDAQ: TNGX) ha annunciato che la CEO Barbara Weber, M.D. parteciperà a un colloquio informale al 2025 Jefferies Global Healthcare Conference il mercoledì 19 novembre 2025, dalle 16:30 alle 16:55 GMT / 11:30–11:55 ET. La sessione sarà trasmessa in diretta via webcast nella scheda Eventi e Presentazioni sulla pagina degli investitori dell'azienda. Una replica sarà archiviata sul sito web dell'azienda per 90 giorni dopo la presentazione.
Tango Therapeutics (NASDAQ: TNGX) anunció que la directora ejecutiva Barbara Weber, M.D. participará en una charla junto a la chimenea en la Conferencia Global de Salud 2025 de Jefferies el miércoles 19 de noviembre de 2025, de 16:30 a 16:55 GMT / 11:30–11:55 AM ET. La sesión estará disponible en directo vía webcast bajo la pestaña de Eventos y Presentaciones en la página de inversores de la empresa. Una repetición quedará archivada en el sitio web de la empresa durante 90 días después de la presentación.
Tango Therapeutics (NASDAQ: TNGX)은 CEO Barbara Weber, M.D.가 2025 Jefferies Global Healthcare Conference에서 2025년 11월 19일 수요일, 16:30–16:55 GMT / 11:30–11:55 AM ET에 파이어사이드 대담에 참여한다고 발표했습니다. 세션은 회사의 투자자 페이지의 Events & Presentations 탭에서 생방송으로 시청할 수 있습니다. 발표 후 재생은 90일 동안 회사 웹사이트에 보관됩니다.
Tango Therapeutics (NASDAQ: TNGX) a annoncé que la PDG Barbara Weber, M.D. participera à une conversation informelle lors de la 2025 Jefferies Global Healthcare Conference le mercredi 19 novembre 2025, de 16h30 à 16h55 GMT / 11h30 à 11h55 ET. La session sera disponible en direct via webcast sous l'onglet Événements et Présentations sur la page Investisseurs de l'entreprise. Une rediffusion sera archivée sur le site Web de l'entreprise pendant 90 jours après la présentation.
Tango Therapeutics (NASDAQ: TNGX) gab bekannt, dass CEO Barbara Weber, M.D. an einem Fireside-Chat auf der 2025 Jefferies Global Healthcare Conference am Mittwoch, dem 19. November 2025, 16:30–16:55 GMT / 11:30–11:55 ET teilnehmen wird. Die Sitzung wird live per Webcast unter dem Reiter Events & Presentations auf der Investorenseite des Unternehmens verfügbar sein. Eine Wiederholung wird auf der Website des Unternehmens 90 Tage nach der Präsentation archiviert.
Tango Therapeutics (NASDAQ: TNGX) أعلنت أن الرئيسة التنفيذية Barbara Weber, M.D. ستشارك في محادثة بجلسة fireside في مؤتمر Jefferies العالمي للرعاية الصحية 2025 يوم الأربعاء 19 نوفمبر 2025، من 4:30 إلى 4:55 مساءً بتوقيت GMT / 11:30–11:55 صباحاً بتوقيت ET. ستتوفر الجلسة مباشرة عبر البث عبر الويب ضمن علامة التبويب الأحداث والعروض في صفحة المستثمرين بالشركة. ستُرْصد إعادة للبث على موقع الشركة لمدة 90 يوماً بعد العرض.
- None.
- None.
BOSTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday, November 19 at 4:30-4:55 PM GMT / 11:30-11:55am ET.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
FAQ
When will Tango Therapeutics (TNGX) present at the Jefferies Global Healthcare Conference on November 19, 2025?
How can investors watch Tango Therapeutics (TNGX) live at the Jefferies conference?
Will there be a replay of Tango Therapeutics (TNGX) presentation from the Jefferies conference?
Who is representing Tango Therapeutics (TNGX) at the 2025 Jefferies Global Healthcare Conference?
What topics will Tango Therapeutics (TNGX) cover at the Jefferies Global Healthcare Conference?
Where on the Tango Therapeutics (TNGX) site is the Jefferies conference webcast posted?
